Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

337
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
337
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

225
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
225
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

257
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
257
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

1.1K
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
1.1K
Flail Chest-II01:26

Flail Chest-II

270
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
270

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Supercritical Fluid Extraction of Ergosterol from <i>Lentinula edodes</i> and <i>Pleurotus ostreatus</i>: Optimization and Synergistic Effects of Biomass Pre-Treatments.

Molecules (Basel, Switzerland)·2026
Same author

Virtual reality-based mindfulness interventions on employees' well-being within organizational contexts: A scoping review.

Acta psychologica·2026
Same author

Lepromatous leprosy presenting with chronic painless ulcers and inflammatory arthropathy: a case report from a non-endemic setting.

BMC infectious diseases·2026
Same author

Lipidomic Signatures in Feline Disease: A PRISMA-Guided Systematic Review.

Metabolites·2026
Same author

Navigating uncertainty in early motherhood: addressing psychological needs during the postpartum period.

Psychology & health·2026
Same author

Effects of Live and Heat-Treated Bifidobacterium longum CECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double-Blind, Placebo-Controlled Trial.

Allergy·2026

Related Experiment Video

Updated: Oct 2, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K

Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome.

Débora Gouveia1,2, Mariana Chichorro3, Ana Cardoso1

  • 1Arrábida Veterinary Hospital-Lisbon Animal Regenerative and Rehabilitation Center, 2675-655 Odivelas, Portugal.

Veterinary Sciences
|February 24, 2022
PubMed
Summary

Hyperbaric oxygen therapy (HBOT) is a safe and tolerable treatment for dogs with Systemic Inflammatory Response Syndrome (SIRS). Early application of HBOT is recommended for improved clinical outcomes in affected canine patients.

Keywords:
ATAHBOTSIRSdogstraumatic

More Related Videos

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.0K
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.1K

Related Experiment Videos

Last Updated: Oct 2, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

2.9K
Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome
06:06

Oleic Acid-Injection in Pigs As a Model for Acute Respiratory Distress Syndrome

Published on: October 26, 2018

10.0K
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
07:40

A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation

Published on: August 30, 2019

9.1K

Area of Science:

  • Veterinary Medicine
  • Critical Care
  • Oxygen Therapy

Background:

  • Systemic Inflammatory Response Syndrome (SIRS) is a critical condition in dogs, often resulting from trauma or other diseases.
  • Hyperbaric oxygen therapy (HBOT) is explored for its potential anti-inflammatory effects.
  • The study investigates HBOT's role in managing SIRS in canine patients.

Purpose of the Study:

  • To assess the safety and tolerability of HBOT in dogs diagnosed with SIRS.
  • To evaluate the efficacy of HBOT as a primary or adjunctive treatment for SIRS in dogs.

Main Methods:

  • A prospective cohort study involving 49 SIRS-positive dogs, categorized into traumatic (n=32) and non-traumatic (n=17) groups.
  • Dogs underwent HBOT sessions lasting 60-90 minutes at pressures of 2.4-2.8 ATA.
  • Data collected included clinical outcomes and adverse events related to HBOT.

Main Results:

  • 73.5% (36/49) of dogs demonstrated clinical improvement following HBOT.
  • The average number of HBOT sessions was 12.73, with a minimum of two sessions required for improvement.
  • Earlier initiation of HBOT after diagnosis was significantly correlated with better clinical outcomes (p=0.031).

Conclusions:

  • HBOT is a safe and well-tolerated therapeutic option for canine patients with SIRS.
  • Prompt administration of HBOT is crucial for maximizing positive clinical outcomes in SIRS-positive dogs.
  • Further research may explore HBOT's specific mechanisms in managing canine SIRS.